Brief: Allurion Technologies Q3 Revenue USD 2.658 Million
12/11/2025 13:00
Nov 12 (Reuters) - Allurion Technologies Q3 income from operations USD -9.63 million. Q3 operating expenses USD 10.934 million Q3 gross profit USD 1.304 million Q3 pretax profit USD -11.875 million
Recent news on Allurion Technologies
See all newsBrief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
Brief: NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc.
Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina
Allurion rises after strong weight-loss data from combination therapy